The tariff classification of two portable oxygen concentrators from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for both portable oxygen concentrators will be 9019.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[o]zone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus; parts and accessories thereof.” The general rate of duty will be free.
Ruling text
In your letter dated May 1, 2025, you requested a tariff classification ruling of portable oxygen concentrators (POCs), accessories, and spare parts. In your May 27, 2025 email, you clarify that you only seek the classification of the POCs. User manuals and a brochure were provided.
The products under consideration are the X-PLOR portable oxygen concentrator and the DISCOV-R portable oxygen concentrator for patients requiring respiratory therapy, whose physicians have prescribed concentrated oxygen (typically above 82%) in order to enhance their blood oxygen saturation. The X-PLOR portable oxygen concentrator measures 7.3 x 2.9 x 7.6 inches (L x W x H) and weighs 3.75 lbs. The unit is a portable, software-monitored oxygen delivery system and features Bluetooth capability.
The POC delivers concentrated oxygen in pulse mode (five settings) by responding to the patient’s inhalations or in no breath detected mode (auto pulse flow at 15 breaths per minute at selected setting). The DISCOV-R portable oxygen concentrator measures 9.9 x 4.1 × 7.9 (L x W x H) inches and weighs 6.5 lbs. The unit is portable, software-monitored oxygen delivery system and features Bluetooth capability.
The POC delivers concentrated oxygen in pulse mode by responding to the patient’s inhalations, in continuous flow mode, and in no breath detected mode. The principle of operation of both portable devices is to deliver supplemental oxygen by respiration demand. The POC brings in external air through an intake filter. The filtered air flows into a compressor where it is pressurized. Electronic valves are used to control the flow of air by the means of a microprocessor.
The compressed air flows through a molecular sieve bed which removes the nitrogen and provides oxygen to the user based on the selected flow setting. Oxygen purity concentration ranges typically from 86% to 96% for all flow settings.
The applicable subheading for both portable oxygen concentrators will be 9019.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[o]zone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus; parts and accessories thereof.” The general rate of duty will be free.
Effective March 4, 2025, pursuant to U.S. Note 2(u) to Subchapter III, Chapter 99, all products of China and Hong Kong as provided by heading 9903.01.24, HTSUS, other than products classifiable under headings 9903.01.21, 9903.01.22, and 9903.01.23, HTSUS, will be subject to an additional 20 percent ad valorem rate of duty. At the time of entry, you must report the applicable Chapter 99 heading, i.e. 9903.01.24, in addition to subheading 9019.20.0000, HTSUS, listed above.
Effective April 5, 2025, Executive Orders implemented “Reciprocal Tariffs.” All imported merchandise must be reported with either the Chapter 99 provision under which the reciprocal tariff applies or one of the Chapter 99 provisions covering exceptions to the reciprocal tariffs. At this time products from all countries will be subject to an additional 10 percent ad valorem rate of duty.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N348475).